1. Screening with Spirometry Is a Useful Predictor of Later Development of Noninfectious Pulmonary Syndromes in Patients Undergoing Allogeneic Stem Cell Transplantation 
Philip A. Thompson, Andrew Lim, Yvonne Panek-Hudson, Mark Tacey, Ramzi Hijazi, Ashley P. Ng, Jeff Szer, David Ritchie, Ashish Bajel 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 6, Pages (June 2014)
DOI: /j.bbmt
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(Left) Cumulative incidence with time of patients developing NIPS. (Right) Cumulative incidence according to whether NIPS was identified by symptoms or by screening.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Median ΔFEV1.0 between baseline and D100 in patients who developed NIPS was −12% (interquartile range [IQR], −25% to −1%) compared with −1% (IQR, −7% to 6%) in unaffected recipients (P = .002). From D100 to 1 year, median ΔFEV1.0 in patients who developed NIPS was −20% (IQR, −28% to 2%) compared with 0% (IQR, −7% to 9%) in unaffected patients (P = .002). Between baseline and 1 year, median ΔFEV1.0 was −19% (IQR, −37% to −6%) in patients developing NIPS versus to −3% (IQR, −10% to 4%) in unaffected patients (P < .001).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
ROC curves for prediction of NIPS using change in FEV1.0 at different assessment time points.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions